Robuta

Sponsor of the Day: Jerkmate
https://www.propharmagroup.com/services/regulatory-sciences/fda-regulatory-consulting/fda-meetings/ FDA Meeting Consulting Services from ProPharma's Regulatory Sciences Expert FDA Meeting consultants from ProPharma have decades of experience meeting with the FDA, and continue to do so on a weekly basis. fda meetingconsulting servicespropharmaregulatorysciences https://www.biospace.com/press-releases/oncolytics-biotech-announces-type-c-fda-meeting-to-discuss-single-arm-registrational-pathway-for-pelareorep-in-anal-cancer Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for... announces typefda meetingsingle armoncolyticsdiscuss https://montrealgazette.com/press-releases/globe-newswire/oncolytics-biotech-announces-type-c-fda-meeting-to-discuss-single-arm-registrational-pathway-for-pelareorep-in-anal-cancer/ Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for... SAN DIEGO, April 06, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy announces typefda meetingsingle armoncolyticsdiscuss https://www.manilatimes.net/2026/04/07/tmt-newswire/globenewswire/organogenesis-announces-successful-fda-meeting-and-plan-to-file-bla-for-renu-for-knee-osteoarthritis-pain/2315030 Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee... Apr 7, 2026 - Clinical Development Program Appropriate for Rolling BLA announces successfulfda meetingorganogenesisplanfile https://www.fda.gov/advisory-committees/pharmacy-compounding-advisory-committee/meeting-pharmacy-compounding-advisory-committee Meeting of the Pharmacy Compounding Advisory Committee | FDA February 2027 Meeting of the Pharmacy Compounding Advisory Committee pharmacy compounding advisorymeetingcommitteefda https://www.fda.gov/drugs/development-resources/model-informed-drug-development-paired-meeting-program Model-Informed Drug Development Paired Meeting Program | FDA FDA is conducting a MIDD Pilot Program to facilitate the development and application of exposure-based, biological, and statistical models derived from... informed drugmeeting programmodeldevelopmentpaired https://www.fda.gov/drugs/novel-drug-approvals-fda/critical-path-innovation-meeting-cpim-topics-held-date Critical Path Innovation Meeting (CPIM) Topics Held to Date | FDA Critical Path Innovation Meeting (CPIM) Topics Held to Date critical pathinnovationmeetingcpimtopics https://www.fda.gov/drugs/development-resources/complex-innovative-trial-design-meeting-program Complex Innovative Trial Design Meeting Program | FDA As displayed in the Federal Register notice on August 1, 2018, FDA is conducting a Complex Innovative Designs (CID) Meeting Program to support the goal of... trial designmeeting programcomplexinnovativefda https://www.fda.gov/about-fda/visitor-information/public-meeting-information Public Meeting Information | FDA Public Meeting Information public meetinginformation fda https://www.newswire.ca/news-releases/mindmed-announces-successful-completion-of-pre-ind-meeting-with-the-fda-for-project-lucy-893361153.html MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy Dec 14, 2020 - /CNW/ -- MindMed (NEO: MMED, OTCQB: MMEDF, DE: MMQ), a leading psychedelic medicine biotech company today announced the successful completion of a pre-IND... announces successfulcompletionpreindmeeting